Cardio Diagnostics Holdings, Inc. and Truckers Health Network Enter Into a Strategic Collaboration to Accelerate Cardiovascular Health Initiatives in the Trucking Industry
September 07 2023 - 8:01AM
Business Wire
Cardio Diagnostics Holdings, Inc. (Nasdaq: CDIO), a pioneer of
artificial intelligence-driven precision cardiovascular medicine
tests, today announced a strategic collaboration with Truckers
Health Network, an organization providing health and wellness
options to truckers and trucking companies. Truckers are
disproportionately affected by heart disease and this partnership
marks a significant commitment by both organizations to address the
urgent need for heart disease prevention and control among trucking
professionals.
By combining Cardio Diagnostics’ cutting-edge cardiovascular
diagnostic offerings, remotely deployable on the road, at offices,
and in warehouses, with Truckers Health Network’s customized
corporate wellness programming, the collaboration aims to
exponentially expand the number of trucking professionals and
trucking company staff with access to these crucial resources.
According to the American Heart Journal Plus, the trucking
industry, characterized by demanding work conditions and lifestyle
challenges, has seen an alarming rise in cardiovascular disease
prevalence. Recognizing the severity of this crisis, Cardio
Diagnostics and Truckers Health Network have pledged to
dramatically improve accessibility to heart health solutions for
truckers, their families, and their employers.
This new jointly-developed offer includes a one-stop-shop for
trucking companies tackling heart disease in their employees to
deploy cutting-edge clinical tests followed by enhanced employee
wellness resources to manage heart disease. Trucking companies that
sign up can expect to increase the number of employees who
participate remotely via telemedicine or through regular onsite
heart disease fairs that bring the tests and education to the
employees via mobile clinics and clinicians.
With Cardio’s Employer Risk Intelligence platform, employers
that offer Cardio’s tests gain valuable and actionable insights on
cardiovascular disease risk across their employee population in a
HIPAA-compliant manner to better determine resources they may need
to provide to their employees at risk for or have heart
disease.
Cardio Diagnostics will participate in Truckers Health Network’s
seminal 2023 TruckersCon event, taking place in November 2023 in
Mesa, Arizona, to drive momentum within the broader industry for
addressing health in the trucking, transportation, and logistics
industries overall. Brian Hazelgren, Chairman of Truckers Health
Network, said, “This partnership with Cardio Diagnostics signals a
transformational leap toward fostering a new era of cardiovascular
wellness for the trucking community. Together, we are dedicated to
developing customized solutions for the trucking industry to
substantially reduce heart disease rates, creating a win-win for
trucking companies and their employees.”
Meesha Dogan, Ph.D., Cardio Diagnostics’ CEO and Co-Founder,
remarked, "The intersection of advanced cardiovascular technology
and the critical infrastructure of our nation's trucking industry
presents an unprecedented opportunity for transformative impact. At
Cardio Diagnostics, in partnership with Truckers Health Network,
we're strategically positioning ourselves to address the nuanced
challenges trucking professionals face. It's not merely about
deploying state-of-the-art diagnostics; it's about architecting a
holistic and sustainable framework for health rooted in data-driven
insights and rigorous analytical approaches. Our ambition
transcends diagnostics—we envision a paradigm where prevention is
integrated seamlessly into the fabric of the trucking industry's
operational model."
This strategic alignment between Cardio Diagnostics and Truckers
Health Network is poised to redefine the paradigm for heart health
among truckers and transportation staff. By joining forces, the
partners aim to leave a lasting impact by improving outcomes for
trucking professionals and shaping the future landscape of
cardiovascular wellness nationwide.
About Cardio Diagnostics
Cardio Diagnostics is an artificial intelligence-powered
precision cardiovascular medicine company that makes cardiovascular
disease prevention, detection, and management more accessible,
personalized, and precise. The Company was formed to further
develop and commercialize clinical tests by leveraging a
proprietary Artificial Intelligence (AI)-driven Integrated
Genetic-Epigenetic Engine (“Core Technology”) for cardiovascular
disease to become one of the leading medical technology companies
for improving prevention, detection, and treatment of
cardiovascular disease. For more information, please visit
www.cardiodiagnosticsinc.com.
Forward-Looking Statements
Certain statements and information included in this press
release constitute "forward-looking statements" within the meaning
of the Private Securities Litigation Act of 1995. When used in this
press release, the words or phrases “will”, "will likely result,"
"expected to," "will continue," "anticipated," "estimate,"
"projected," "intend," “goal,” or similar expressions are intended
to identify "forward-looking statements" within the meaning of the
Private Securities Litigation Reform Act of 1995. Such statements
are subject to certain risks, known and unknown, and uncertainties,
many of which are beyond the control of the Company. Such
uncertainties and risks include but are not limited to, our ability
to successfully execute our growth strategy, changes in laws or
regulations, economic conditions, dependence on management,
dilution to stockholders, lack of capital, the effects of rapid
growth upon the Company and the ability of management to
effectively respond to the growth and demand for products and
services of the Company, newly developing technologies, the
Company’s ability to compete, regulatory matters, protection of
technology, the effects of competition and the ability of the
Company to obtain future financing. An extensive list of factors
that can affect future results are discussed in the Current Report
on Form 10-K for the period ended December 31, 2022 and Form 10-Q
for the period ended June 30, 2023 under the heading “Risk Factors”
in Part I, Item IA thereof, and other documents filed from time to
time with the Securities and Exchange Commission. Such factors
could materially adversely affect the Company's financial
performance and could cause the Company's actual results for future
periods to differ materially from any opinions or statements
expressed within this press release.
About Truckers Health Network
Truckers Health Network (THN) is on a mission to support the
health and well-being of truck drivers across America. With a focus
on providing compassionate, judgment-free support, THN aims to
break down the barriers truckers face to maintaining their physical
and mental health on the road. The company aims to provide
innovative solutions for HR, benefits, and risk leaders through
healthcare, benefits, and wellness solutions. Learn more about THN
on their website.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230907800761/en/
Investors: Gene Mannheimer Investor Relations 855-226-9991
investors@cardiodiagnosticsinc.com
Media & Public Relations: Khullani Abdullahi
pr@cardiodiagnosticsinc.com
Cardio Diagnostics (NASDAQ:CDIO)
Historical Stock Chart
From May 2024 to Jun 2024
Cardio Diagnostics (NASDAQ:CDIO)
Historical Stock Chart
From Jun 2023 to Jun 2024